Adage Capital Partners’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-408,901
| Closed | -$3.35M | – | 700 |
|
|
2017
Q3 | $3.35M | Sell |
408,901
-50,000
| -11% | -$410K | 0.01% | 651 |
|
|
2017
Q2 | $2.06M | Sell |
458,901
-25,000
| -5% | -$112K | 0.01% | 666 |
|
|
2017
Q1 | $2.67M | Sell |
483,901
-50,000
| -9% | -$275K | 0.01% | 655 |
|
|
2016
Q4 | $2.16M | Sell |
533,901
-623,148
| -54% | -$2.52M | 0.01% | 648 |
|
|
2016
Q3 | $8.16M | Sell |
1,157,049
-392,951
| -25% | -$2.77M | 0.02% | 552 |
|
|
2016
Q2 | $12.6M | Buy |
1,550,000
+400,000
| +35% | +$3.26M | 0.03% | 471 |
|
|
2016
Q1 | $9.35M | Buy |
1,150,000
+300,000
| +35% | +$2.44M | 0.03% | 534 |
|
|
2015
Q4 | $10.3M | Buy |
850,000
+500,000
| +143% | +$6.03M | 0.03% | 518 |
|
|
2015
Q3 | $4.19M | Buy |
350,000
+50,000
| +17% | +$599K | 0.01% | 626 |
|
|
2015
Q2 | $5.5M | Buy |
+300,000
| New | +$5.5M | 0.01% | 626 |
|